Zobrazeno 1 - 10
of 407
pro vyhledávání: '"Sakae, Homma"'
Autor:
Atsushi Miyamoto, Hirofumi Michimae, Yasuharu Nakahara, Shinobu Akagawa, Kazuhiko Nakagawa, Yuji Minegishi, Takashi Ogura, Shigeto Hontsu, Hiroshi Date, Kazuhisa Takahashi, Sakae Homma, Kazuma Kishi, Investigators Group for Lung Cancer and IIP
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-14 (2024)
Abstract Effective treatment for advanced lung cancer and idiopathic interstitial pneumonia (IIP) remains an unmet medical need. The relationship between chemotherapy’s effectiveness in advanced lung cancer and the risk of acute exacerbation of IIP
Externí odkaz:
https://doaj.org/article/e324891d132b401ca7a0d805bde41bac
Autor:
Takumi Motohashi, Kazutoshi Isobe, Takahiro Yoshizawa, Yusuke Usui, Hiroshige Shimizu, Muneyuki Sekiya, Shion Miyoshi, Yasuhiko Nakamura, Naohisa Urabe, Susumu Sakamoto, Sakae Homma, Sota Sadamoto, Naobumi Tochigi, Kazuma Kishi
Publikováno v:
Respirology Case Reports, Vol 12, Iss 3, Pp n/a-n/a (2024)
Abstract A 66‐year‐old woman was found to have abnormal shadows on a chest radiograph at a previous hospital 4 years ago, which led to a diagnosis of lung adenocarcinoma, cT2aN1M1b stage IVA. First‐line treatment included carboplatin and paclit
Externí odkaz:
https://doaj.org/article/59796f49e9294fa2a14ea440c1b13db5
Autor:
Susumu Sakamoto, Aika Suzuki, Sakae Homma, Yusuke Usui, Hiroshige Shimizu, Muneyuki Sekiya, Shion Miyoshi, Yasuhiko Nakamura, Naohisa Urabe, Takuma Isshiki, Atsuko Kurosaki, Kazuma Kishi
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Approximately one-third of fibrosing interstitial lung diseases exhibit progressive pulmonary fibrosis (PPF), a clinicopathological condition distinct yet resembling idiopathic pulmonary fibrosis (IPF). PPF in ANCA-positive ILD (ANCA-ILD) is
Externí odkaz:
https://doaj.org/article/fca5c5f79d9f441283470374b6645dbc
Autor:
Naohisa Urabe, Susumu Sakamoto, Marie Masuoka, Chiaki Kato, Asuka Yamaguchi, Nozomi Tokita, Sakae Homma, Kazuma Kishi
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background In Mycobacterium avium complex pulmonary disease (MAC-PD), diagnosis requires a positive culture from at least two separate expectorated sputum specimens. The optimal number of sputum examinations remains unclear. Objective This s
Externí odkaz:
https://doaj.org/article/30c4d5d7a81a4dbbabeab7582af0faf1
Autor:
Naohisa Urabe, Susumu Sakamoto, Yui Shimanuki, Takumi Kanokogi, Takumi Motohashi, Nanami Anzai, Chiaki Kato, Asuka Yamaguchi, Nozomi Tokita, Sakae Homma, Kazuma Kishi
Publikováno v:
BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background The impact of co-infection with other pathogenic microorganisms after initiation of treatment for Mycobacterium avium complex pulmonary disease (MAC-PD) has not been clearly described. This study sought to clarify the clinical out
Externí odkaz:
https://doaj.org/article/0e544900f91840249d79592bd3c4d95b
Autor:
Yasuhiro Kondoh, Takafumi Suda, Yoshie Hongo, Manami Yoshida, Shinzo Hiroi, Kosuke Iwasaki, Tomomi Takeshima, Sakae Homma
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-8 (2022)
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a cryptogenic chronic interstitial pneumonia with progressive fibrosis and a poor prognosis. A substantial number of epidemiological studies have been conducted in Europe and the United State
Externí odkaz:
https://doaj.org/article/a8b80e1f483d40e3814da6eba1ea966f
Autor:
Susumu Sakamoto, Hiroshige Shimizu, Takuma Isshiki, Yasuhiko Nakamura, Yusuke Usui, Atsuko Kurosaki, Kazutoshi isobe, Yujiro Takai, Sakae Homma
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is often fatal. A straightforward staging system for AE-IPF would improve prognostication, guide patient management, and facilitate research. The aim of study is to develop a multi
Externí odkaz:
https://doaj.org/article/b7720550e1c34bf68d6dd4d06b5c63e4
Autor:
Yoshinori Hasegawa, Yasuhiko Nishioka, Shinyu Izumi, Sakae Homma, Yoshikazu Inoue, Takumi Kishimoto, Yutaro Nakamura, Takafumi Suda, Kazuya Ichikado, Takeshi Johkoh, Naoki Hamada, Koichi Hagiwara, Akira Hebisawa, Naohiko Inase, Ryoko Egashira, Kinya Abe, Masaki Okamoto, Motoyasu Kato, Yasuhiro Terasaki, Yuko Toyoda, Tomohisa Baba, Yuji Fujikura, Etsuo Fujita, Tomohiro Handa, Koko Hidaka, Takeshi Hisada, Shu Hisata, Chisato Honjo, Keisuke Miki, Masamichi Mineshita, Susumu Sakamoto, Masaaki Sano, Yoshikazu Tsukada, Mari Yamasue, Yoshimi Bando
Publikováno v:
BMJ Open Respiratory Research, Vol 9, Iss 1 (2022)
Background Diffuse pulmonary ossification is a specific lung condition that is accompanied by underlying diseases. However, idiopathic dendriform pulmonary ossification (IDPO) is extremely rare, and the clinical features remain unclear. In this study
Externí odkaz:
https://doaj.org/article/8c58aad29edf4c72b4c8c6193b072fe5
Autor:
Takuma Isshiki, Kazuya Koyama, Sakae Homma, Susumu Sakamoto, Akira Yamasaki, Hiroshige Shimizu, Shion Miyoshi, Yasuhiko Nakamura, Kazuma Kishi
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract TOLLIP polymorphism has been implicated in the development and prognosis of idiopathic pulmonary fibrosis (IPF), mainly in whites. However, ethnic differences in the characteristics of other interstitial pneumonia (non-IPF) subtypes are uncl
Externí odkaz:
https://doaj.org/article/be2e0b01024042e48bc9da9e0eee92ae
Autor:
Keishi Sugino, Hirotaka Ono, Natsumi Watanabe, Masahiro Ando, Eiyasu Tsuboi, Sakae Homma, Kazuma Kishi
Publikováno v:
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Although antifibrotic drugs, including nintedanib and pirfenidone, slow the progression of idiopathic pulmonary fibrosis (IPF), there is little data about the timing of start of antifibrotic treatment in real-world clinical practi
Externí odkaz:
https://doaj.org/article/082e2c58b56f4c4cbb7b7e068fc1a660